Immunogeniciteten af den aktuelle formulering af vaccinen er blevet bekræftet hos 135 voksne, hvoraf ca. halvdelen var ældre personer.
The immunogenicity of the current formulation of the vaccine has been confirmed in 135 adults, around half of whom were elderly.